Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion type Assertion NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_head.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion description "[Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_provenance.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion evidence source_evidence_literature NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_provenance.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion SIO_000772 23020798 NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_provenance.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion wasDerivedFrom befree-2016 NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_provenance.
- NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_assertion wasGeneratedBy ECO_0000203 NP1016355.RAfG5reFTTbWeeCK5w2dwN_ebUOsNzlVjdr-eutn9qI0M130_provenance.